• Hypertrophic Cardiomyopathy (HCM)
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Locking down privacy


Deborah Peel, MD, knows patient data can be protected as well as leveraged for analytical research, but the infrastructure must be redesigned for granular control

Deborah Peel, MD, is the founder of Patient Privacy Rights (PPR), a national not-for-profit watchdog coalition. As a physician, she was inspired to adopt privacy as her mission in 1993 after an unnerving proposal from President Bill Clinton called for every patient encounter in America to be recorded in an electronic data-base. She was intimately familiar with the anxiety related to privacy in her own psychiatric-services practice, but the broad reach of electronic health records posed an imminent threat she just couldn't ignore.

From the very first week she began in practice, patients offered to pay for treatment out of pocket if she would agree to conceal their visits from insurance plans. A Distinguished Fellow of the American Psychiatric Assn., Dr. Peel says she didn't learn about the tremendous task of managing privacy from medical school; she learned it from her patients. Each patient has an individual expectation for how his or her privacy must be maintained, and most want extremely granular control of how health data is used, not a collective policy.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.